Oregel-Cortez et al. demonstrated that EVs isolated from resistin-treated prostate cancer PC3 cells were more invasive due to increased p-FAK levels as well as increased secretion of the metalloproteinases MMP-2 and MMP-9 [76] in vitro. The gene discussed is PTK2; the disease is prostate cancer.